Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8662652 | International Journal of Cardiology | 2018 | 4 Pages |
Abstract
PAR-4 is expressed in mouse cardiac fibroblasts and is dynamically regulated by extracellular glucose in vitro and diabetes in vivo, thereby impacting on fibroblast functions relevant for cardiac remodelling. These findings add further evidence for the usefulness of the recently developed PAR-4 antagonists in clinical settings.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sonja Kleeschulte, Johann Jerrentrup, Daniel Gorski, Joachim Schmitt, Anke C. Fender,